Azzad Asset Management’s Medtronic MDT Stock Holding History

Azzad Asset Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.62M	Buy	84,606 +16,859	+25%	+$1.36M	0.59%	34
2026 Q1	$5.87M	Sell	67,747 -244	-0.4%	-$23.4K	0.59%	34
2025 Q4	$6.53M	Buy	67,991 +812	+1%	+$78.9K	0.64%	21
2025 Q3	$6.4M	Buy	67,179 +1,200	+2%	+$110K	0.63%	24
2025 Q2	$5.75M	Buy	65,979 +3,795	+6%	+$322K	0.62%	28
2025 Q1	$5.59M	Sell	62,184 -74	-0.1%	-$6.62K	0.66%	23
2024 Q4	$4.97M	Buy	62,258 +1,902	+3%	+$165K	0.96%	19
2024 Q3	$5.43M	Buy	60,356 +574	+1%	+$48.3K	0.61%	25
2024 Q2	$4.71M	Buy	59,782 +1,030	+2%	+$84.4K	0.55%	39
2024 Q1	$5.12M	Buy	58,752 +937	+2%	+$80K	0.6%	36
2023 Q4	$4.76M	Buy	57,815 +9,774	+20%	+$745K	0.6%	35
2023 Q3	$3.76M	Buy	48,041 +509	+1%	+$42.6K	0.53%	48
2023 Q2	$4.19M	Buy	47,532 +750	+2%	+$64.6K	0.56%	43
2023 Q1	$3.77M	Buy	46,782 +468	+1%	+$38.1K	0.54%	48
2022 Q4	$3.6M	Sell	46,314 -33,004	-42%	-$2.67M	0.57%	43
2022 Q3	$6.83M	Buy	79,318 +873	+1%	+$78.5K	0.69%	19
2022 Q2	$7.12M	Buy	78,445 +43,924	+127%	+$4.45M	0.7%	18
2022 Q1	$3.83M	Buy	34,521 +4,697	+16%	+$496K	0.55%	39
2021 Q4	$3.09M	Buy	29,824 +789	+3%	+$91.4K	0.41%	76
2021 Q3	$3.64M	Buy	29,035 +464	+2%	+$60.1K	0.54%	44
2021 Q2	$3.55M	Sell	28,571 -19,643	-41%	-$2.47M	0.53%	43
2021 Q1	$5.7M	Buy	48,214 +5,770	+14%	+$676K	0.94%	9
2020 Q4	$4.97M	Buy	42,444 +2,077	+5%	+$229K	0.9%	9
2020 Q3	$4.19M	Buy	40,367 +1,287	+3%	+$129K	0.87%	12
2020 Q2	$3.58M	Buy	39,080 +5,000	+15%	+$479K	0.84%	15
2020 Q1	$3.07M	Sell	34,080 -42,211	-55%	-$4.49M	0.9%	11
2019 Q4	$7.81M	Buy	76,291 +1,100	+1%	+$121K	0.92%	11
2019 Q3	$7.51M	Buy	75,191 +35,426	+89%	+$3.7M	0.93%	11
2019 Q2	$3.87M	Buy	39,765 +2,822	+8%	+$258K	1.06%	5
2019 Q1	$3.36M	Buy	36,943 +1,037	+3%	+$92.8K	0.98%	9
2018 Q4	$3.27M	Sell	35,906 -5,617	-14%	-$525K	1.1%	5
2018 Q3	$4.08M	Sell	41,523 -987	-2%	-$91.3K	1.09%	5
2018 Q2	$3.64M	Buy	42,510 +1,415	+3%	+$118K	1.04%	7
2018 Q1	$3.3M	Buy	41,095 +3,003	+8%	+$248K	1%	7
2017 Q4	$3.08M	Buy	38,092 +11,429	+43%	+$915K	0.97%	12
2017 Q3	$2.07M	Buy	26,663 +14,906	+127%	+$1.24M	0.69%	23
2017 Q2	$1.04M	Buy	11,757 +1,545	+15%	+$130K	0.37%	94
2017 Q1	$823K	Buy	+10,212	New	+$798K	0.31%	129
2015 Q3	–	Sell	-17,000	Closed	-$1.26M	–	254
2015 Q2	$1.26M	Sell	17,000 -1,065	-6%	-$81.4K	0.64%	38
2015 Q1	$1.41M	Buy	18,065 +10,722	+146%	+$813K	0.68%	30
2014 Q4	$530K	Buy	7,343 +1,163	+19%	+$80.8K	0.28%	151
2014 Q3	$383K	Buy	6,180 +305	+5%	+$19.4K	0.22%	187
2014 Q2	$375K	Buy	5,875 +178	+3%	+$10.8K	0.23%	186
2014 Q1	$351K	Buy	5,697 +816	+17%	+$47.5K	0.23%	189
2013 Q4	$280K	Buy	4,881 +603	+14%	+$34.2K	0.2%	205
2013 Q3	$228K	Hold	4,278	–	–	0.19%	207
2013 Q2	$225K	Buy	+4,278	New	+$211K	0.19%	206

Other funds holding MDT

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

GAM

Guinness Asset Management London, United Kingdom $5.91B AUM 21.44% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

SRIM

Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Azzad Asset Management's MDT Position: Q2 2026 in Review

Azzad Asset Management increased its Medtronic (MDT) stake by 25% in Q2 2026, buying an estimated $1.36M and bringing the position to 84,606 shares worth $6.62M. The position accounts for 0.59% of the portfolio, ranked #34.

Azzad Asset Management first reported a position in MDT in Q2 2013 and has held it in 47 quarters since. The position peaked at $7.81M in Q4 2019. 961 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

Azzad Asset Management held 84,606 shares of Medtronic worth $6.62M as of Q2 2026.
Azzad Asset Management bought 16,859 Medtronic shares in Q2 2026, an estimated $1.36M.
Medtronic made up 0.59% of Azzad Asset Management's portfolio in Q2 2026, its #34 holding.
Azzad Asset Management first reported a position in Medtronic in Q2 2013 and has held it in 47 quarters since.
Azzad Asset Management's Medtronic position peaked at $7.81M in Q4 2019.
961 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Azzad Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.